Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NXN-188 for Acute Migraine Without Aura
NCT00959751Phase 2Completed
- Sponsor
- NeurAxon Inc.
- Start
- Jul 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NXN-188 in migraine without aura, sponsored by NeurAxon Inc.. Started Jul 2009; status: completed.
02
Drugs
NXN-188
03
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT00959751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959751.